DR info

Clinical trials : 25 / Drugs : 35 - (DrugBank : 13) / Drug target genes : 16 - Drug target pathways : 22

Hemiconvulsion hemiplegia epilepsy syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
149	Hemiconvulsion hemiplegia epilepsy syndrome	-
2	Amyotrophic lateral sclerosis	10.172
13	Multiple sclerosis/Neuromyelitis optica	10.091
6	Parkinson disease	8.696
144	Lennox-Gastaut syndrome	4.456
8	Huntington disease	4.168
145	West syndrome	2.980
127	Frontotemporal lobar degeneration	2.700
140	Dorabe syndrome	2.603
86	Pulmonary arterial hypertension	2.351
10	Charcot-Marie-Tooth disease	2.053
256	Muscle glycogenosis	2.040
58	Hypertrophic cardiomyopathy	1.838
90	Retinitis pigmentosa	1.831
34	Neurofibromatosis	1.673
65	Primary immunodeficiency	1.667
97	Ulcerative colitis	1.594
102	Rubinstein-Taybi syndrome	1.588
46	Malignant rheumatoid arthritis	1.566
233	Wolfram syndrome	1.203
206	Fragile X syndrome	1.168
226	Interstitial cystitis with Hunners ulcer	1.132
5	Progressive supranuclear palsy	1.129
202	Smith-Magenis syndrome	1.118
156	Rett syndrome	1.100
85	Idiopathic interstitial pneumonia	1.065